| Tracking early lung cancer metastatic dissemination in TRACERx using ctDNA C Abbosh, AM Frankell, T Harrison, J Kisistok, A Garnett, L Johnson, ... Nature 616 (7957), 553-562, 2023 | 105 | 2023 |
| Using DNA sequencing data to quantify T cell fraction and therapy response R Bentham, K Litchfield, TBK Watkins, EL Lim, R Rosenthal, ... Nature 597 (7877), 555-560, 2021 | 49 | 2021 |
| Treatment represents a key driver of metastatic cancer evolution DS Christensen, J Ahrenfeldt, M Sokač, J Kisistók, MK Thomsen, ... Cancer research 82 (16), 2918-2927, 2022 | 19 | 2022 |
| The ratio of adaptive to innate immune cells differs between genders and associates with improved prognosis and response to immunotherapy J Ahrenfeldt, DS Christensen, AB Østergaard, J Kisistók, M Sokač, ... Plos one 18 (2), e0281375, 2023 | 3 | 2023 |
| Computational Analysis Reveals the Temporal Acquisition of Pathway Alterations during the Evolution of Cancer J Ahrenfeldt, DS Christensen, M Sokač, J Kisistók, N McGranahan, ... Cancers 14 (23), 5817, 2022 | 2 | 2022 |
| Analysis of circulating tumor DNA during checkpoint inhibition in metastatic melanoma using a tumor-agnostic panel J Kisistók, DS Christensen, MH Rasmussen, L Duval, ... Melanoma Research 33 (5), 364-374, 2023 | 1 | 2023 |
| Exploring the biology of ctDNA release in colorectal cancer L Andersen, J Kisistók, TV Henriksen, JB Bramsen, T Reinert, N Øgaard, ... European Journal of Cancer, 114186, 2024 | | 2024 |
| Exploring the biology of ctDNA release in colon cancer J Kisistok, TV Henriksen, JB Bramsen, T Reinert, TB Mattesen, NJ Birkbak, ... Cancer Research 82 (12_Supplement), 3398-3398, 2022 | | 2022 |
| Holistic sampling of clonal dynamics using cfDNA in lung TRACERx AM Frankell, C Abbosh, A Garnett, J Kisistok, T Harrison, M Weichert, ... Cancer Research 82 (12_Supplement), 2144-2144, 2022 | | 2022 |
| Distinct aggressive biology drives the evolution of metastatic cancer DS Christensen, J Ahrenfeldt, M Sokač, J Kisistók, N McGranahan, ... Cancer Research 82 (12_Supplement), 2186-2186, 2022 | | 2022 |
| High relative ratio of adaptive to innate tumor infiltrating immune cells predicts for immunotherapy response and associates with improved prognosis J Ahrenfeldt, AB Østergaard, DS Christensen, J Kisistók, M Sokač, ... Cancer Research 82 (12_Supplement), 2724-2724, 2022 | | 2022 |
| Temporal dissection of altered pathways during the evolution of cancer J Ahrenfeldt, M Sokac, N Birkbak Annals of Oncology 30, vii1, 2019 | | 2019 |
